Stryker Corp (SYK) Dividends

Stryker's dividend is sustainable, with a payout ratio of approximately 39% based on its EPS of $8.40 and annual dividend of $3.30. This is a conservative level, well below the typical 75% threshold that signals risk, indicating significant room for safety and future increases. The company has a consistent history of growing its dividend, which aligns with its 11.4% YoY revenue growth. The 1.02% yield, however, is below the S&P 500 average and typical for a growth-oriented medical device leader, making it less attractive for investors seeking high current income. The dividend is well-covered by free cash flow. With a 3.4% FCF yield, the company generates enough cash to fund the dividend, reinvest in the business, and manage its balance sheet. Referencing the GoodMoat Quality Indicators, the company's balance sheet is adequate with a Debt/Equity ratio of 0.71, which is manageable, though not the substantial net cash position the framework favours. The positive and growing FCF supports the 'Strong' rating for that criterion. The primary consideration for a value investor is valuation; the P/E of 38.6 and the GoodMoat Target price suggest the stock is trading at a premium, which offsets the favourable dividend fundamentals.